Last Updated on January 26, 2021 by The Health Master
The Union Ministry of Ayush has issued a directive to the state licensing authorities for Ayurvedic, Siddha and Unani drugs and all Ayurvedic, Siddha and Unani Drug manufacturers to prevent misleading advertisement and claims of classical / shastriye Ayurvedic, Siddha and Unani (ASU) drugs.
In a circular issued on January 19, 2021, the Ayush ministry stated that recently certain instances of ambiguous statements and unfounded claims to denigrate classical/shastriye ASU drugs have been brought to the notice of Central government, which tantamount to be misleading to the public and appear to be in contravention of the legal provisions for prohibition of advertisement of drugs as well as desist public from consuming such ASU formulations.
All the ASU drug manufacturers in the country are hereby advised not to make and publicize any inappropriate statement or misleading claim against classical/shastriye ASU drug and the State/UT licensing authorities / drug controllers may take necessary action on the instance of denigrating classical ASU formulation in terms of its name and use amounted to misleading in nature under the provisions of Drugs and Magic Remedies Act (Objectionable Advertisement), Act, 1954 and Drugs & Cosmetics Rules, 1945, said the statement issued by the Ministry of Ayush.
Also read | CDSCO: Guidance on Regn & import of cosmetics into India
Whereas the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Drugs & Cosmetics Rules, 1945 have prescribed provisions for prohibition of misleading advertisements and claims of ASU drugs along with penalty provisions for the defaulters.
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
Follow and connect with us on Facebook and Linkedin
Go to main website, click here
Subscribe for daily free updates, click here
For daily free updates on WhatsApp, click here
